Načítá se...
Allergen-specific intralymphatic immunotherapy in human and animal studies
Clinical trials of intralymphatic immunotherapy (ILIT) have been performed to overcome the limitations of long-term therapy and the local or systemic hypersensitivity reactions in conventional allergen-specific immunotherapy, including subcutaneous or sublingual immunotherapy. Additionally, several...
Uloženo v:
| Vydáno v: | Asia Pac Allergy |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5537077/ https://ncbi.nlm.nih.gov/pubmed/28765817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5415/apallergy.2017.7.3.131 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|